Ascendis’ TransCon Positioned To Take On BioMarin’s Voxzogo

Ascendis announced positive Phase III data that hit the mark with investors • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Rare Diseases

More from Scrip